| Atrial Fibrillation Management and Outcomes | Lifetime | 109 | DK 2 | 99.64 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 76 | DK 3 | 99.55 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 295 | DK 7 | 99.10 |
| Cardiovascular Function and Risk Factors | Lifetime | 434 | DK 7 | 99.21 |
| Inflammatory mediators and NSAID effects | Lifetime | 180 | DK 3 | 98.67 |
| Heart Failure Treatment and Management | Lifetime | 224 | DK 4 | 99.14 |
| Cardiac Arrest and Resuscitation | Lifetime | 625 | DK 11 | 98.35 |
| Cardiac Arrhythmias and Treatments | Lifetime | 693 | DK 7 | 98.29 |
| Acute Myocardial Infarction Research | Lifetime | 482 | DK 16 | 98.53 |
| Diabetes Treatment and Management | Lifetime | 600 | DK 31 | 97.87 |
| COVID-19 and healthcare impacts | Lifetime | 645 | DK 4 | 93.66 |
| Cardiac Health and Mental Health | Lifetime | 572 | DK 8 | 96.42 |
| Lipoproteins and Cardiovascular Health | Lifetime | 888 | DK 16 | 96.71 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 597 | DK 13 | 95.00 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 893 | DK 25 | 93.90 |
| Potassium and Related Disorders | Lifetime | 478 | DK 10 | 91.80 |
| Medication Adherence and Compliance | Lifetime | 792 | DK 3 | 91.31 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 750 | DK 14 | 89.13 |
| Acne and Rosacea Treatments and Effects | Lifetime | 829 | DK 14 | 86.38 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 983 | DK 45 | 64.29 |
| Cardiac Arrest and Resuscitation | 2021-2025 | 320 | DK 18 | 96.63 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 429 | DK 10 | 96.95 |
| Heart Failure Treatment and Management | 2021-2025 | 284 | DK 6 | 96.51 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 616 | DK 12 | 96.01 |
| Cardiac electrophysiology and arrhythmias | 2021-2025 | 329 | DK 6 | 95.57 |
| COVID-19 and healthcare impacts | 2021-2025 | 928 | DK 5 | 89.07 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 571 | DK 12 | 93.97 |
| Acute Myocardial Infarction Research | 2021-2025 | 587 | DK 10 | 93.36 |
| Cardiac Health and Mental Health | 2021-2025 | 556 | DK 24 | 86.76 |
| Viral Infections and Immunology Research | 2021-2025 | 747 | DK 6 | 84.41 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 847 | DK 23 | 84.14 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 620 | DK 16 | 72.33 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 539 | DK 18 | 70.83 |
| Healthcare cost, quality, practices | 2021-2025 | 994 | DK 11 | 68.49 |
| Vitamin K Research Studies | 2021-2025 | 193 | DK 7 | 65.14 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 420 | DK 12 | 63.38 |
